CYP2J2/ω-3 DHA epoxides (sEH inhibition) · lipidomics · -
Composite 0.752
Price $0.62
Evidence For 0
Evidence Against 0
The hypothesis proposes that ω-3 docosahexaenoic acid (DHA) is metabolized by CYP2J2 to generate protective epoxides that shield synaptic membranes from amyloid-beta (Aβ)-induced rigidification. Evidence from planar lipid bilayer experiments demonstrates that CYP2J2-derived epoxides mitigate Aβ-induced membrane rigidity (pmid:31243156). Aβ oligomers are known to increase membrane cholesterol content by approximately 40% and expand raft domain size in cortical neurons (pmid:24503041). Supporting
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
NeuroinflammationUnspecified Mechanismlipidomics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
2/11
dimensions won
Astrocyte-Specific DGAT1 Inhibition to P
10/11
dimensions won
ω-3 Docosahexaenoic Acid (DHA) Epoxide G
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
0.80
Evidence
0.55
0.75
Novelty
0.55
0.60
Feasibility
0.40
0.75
Impact
0.55
0.80
Druggability
0.50
0.80
Safety
0.50
0.70
Competition
0.60
0.55
Data
0.55
0.75
Reproducible
0.55
0.75
KG Connect
0.50
0.50
Score Breakdown
Dimension
Astrocyte-Specific DGAT1 Inhib
ω-3 Docosahexaenoic Acid (DHA)
Mechanistic
0.550
0.800
Evidence
0.550
0.750
Novelty
0.550
0.600
Feasibility
0.400
0.750
Impact
0.550
0.800
Druggability
0.500
0.800
Safety
0.500
0.700
Competition
0.600
0.550
Data
0.550
0.750
Reproducible
0.550
0.750
KG Connect
0.500
0.500
Evidence
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet
No evidence citations yet
ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2
No evidence citations yet
Debate Excerpts
Astrocyte-Specific DGAT1 Inhibition to Prevent Lip
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Lipid Metabolism Dysregulation in Alzheimer's Disease
---
## Hypothesis 1: CYP46A1 Activation as a Therapeutic Strategy to Restore Neuronal Cholesterol Efflux and R...
Skeptic
# Critical Evaluation of Lipid Metabolism Hypotheses in Alzheimer's Disease
## Hypothesis 1: CYP46A1 Activation
### Weaknesses in Evidence
The hypothesis presents a linear model of cholesterol ef...
Domain Expert
# Drug Development Assessment: Lipid Metabolism Hypotheses in Alzheimer's Disease
## Executive Summary
The seven hypotheses span a spectrum of druggability—from well-established nuclear receptor a...
# Novel Therapeutic Hypotheses: Lipid Metabolism Dysregulation in Alzheimer's Disease
---
## Hypothesis 1: CYP46A1 Activation as a Therapeutic Strategy to Restore Neuronal Cholesterol Efflux and R...
Skeptic
# Critical Evaluation of Lipid Metabolism Hypotheses in Alzheimer's Disease
## Hypothesis 1: CYP46A1 Activation
### Weaknesses in Evidence
The hypothesis presents a linear model of cholesterol ef...
Domain Expert
# Drug Development Assessment: Lipid Metabolism Hypotheses in Alzheimer's Disease
## Executive Summary
The seven hypotheses span a spectrum of druggability—from well-established nuclear receptor a...